Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1191-1200 of 1,873) with videos related to

Pageof 188
Sort By:
JACC. Heart Failure|July 5, 2023
Prevalent and Incident Anemia in PARADIGM-HF and the Effect of Sacubitril/ValsartanJames P Curtain, Carly Adamson, Kieran F Docherty, et al.
Diabetes Care|October 21, 2020
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering TherapyKieran F Docherty, Pardeep S Jhund, Olof Bengtsson, et al.
Journal of the American College of Cardiology|June 3, 2004
Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarctionDavid Aguilar, Hicham Skali, Lemuel A Moyé, et al.
American Heart Journal|July 6, 2010
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)Faisal Shamshad, Satish Kenchaiah, Peter V Finn, et al.
International Journal of Cardiology|December 1, 2012
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANTSally C Inglis, Judith Bebchuk, Sultan A Al-Suhaim, et al.
Circulation. Heart Failure|October 12, 2017
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial FibrillationSøren Lund Kristensen, Pardeep S Jhund, Ulrik M Mogensen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 4, 2014
Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist deviceDeepak K Gupta, Hicham Skali, Jose Rivero, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 21, 2016
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
JACC. Heart Failure|December 27, 2016
Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC StudyMiguel M Fernandes-Silva, Amil M Shah, Sheila Hegde, et al.
Circulation. Heart Failure|October 4, 2014
Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696Pardeep S Jhund, Brian L Claggett, Adriaan A Voors, et al.
Pageof 188

Showing results (1191-1200 of 1,873) with videos related to

Sort By:
Pageof 188
JACC. Heart Failure|July 5, 2023
Prevalent and Incident Anemia in PARADIGM-HF and the Effect of Sacubitril/ValsartanJames P Curtain, Carly Adamson, Kieran F Docherty, et al.
Diabetes Care|October 21, 2020
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering TherapyKieran F Docherty, Pardeep S Jhund, Olof Bengtsson, et al.
Journal of the American College of Cardiology|June 3, 2004
Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarctionDavid Aguilar, Hicham Skali, Lemuel A Moyé, et al.
American Heart Journal|July 6, 2010
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)Faisal Shamshad, Satish Kenchaiah, Peter V Finn, et al.
International Journal of Cardiology|December 1, 2012
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANTSally C Inglis, Judith Bebchuk, Sultan A Al-Suhaim, et al.
Circulation. Heart Failure|October 12, 2017
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial FibrillationSøren Lund Kristensen, Pardeep S Jhund, Ulrik M Mogensen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 4, 2014
Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist deviceDeepak K Gupta, Hicham Skali, Jose Rivero, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 21, 2016
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
JACC. Heart Failure|December 27, 2016
Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC StudyMiguel M Fernandes-Silva, Amil M Shah, Sheila Hegde, et al.
Circulation. Heart Failure|October 4, 2014
Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696Pardeep S Jhund, Brian L Claggett, Adriaan A Voors, et al.
Pageof 188